Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 45,200 | -4,900 | 82,600 | 48,652 | 15,101 |
| Depreciation Amortization | 24,700 | 12,400 | 44,300 | 29,899 | 20,097 |
| Income taxes - deferred | 8,500 | -4,500 | 3,300 | 18,618 | 4,951 |
| Accounts receivable | -46,200 | 21,800 | -4,800 | 9,411 | 36,160 |
| Accounts payable and accrued liabilities | -4,400 | 3,600 | 16,100 | 2,965 | 4,245 |
| Other Working Capital | -59,400 | -12,400 | 53,700 | 19,587 | 46,609 |
| Other Operating Activity | 65,200 | -17,000 | 12,900 | 1,482 | -31,490 |
| Operating Cash Flow | $33,600 | $-1,000 | $208,100 | $130,614 | $95,673 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22,600 | -11,600 | -54,800 | -42,381 | -29,605 |
| Net Acquisitions | N/A | N/A | -195,100 | N/A | N/A |
| Investing Cash Flow | $-22,600 | $-11,600 | $-249,900 | $-42,381 | $-29,605 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,500 | 4,700 | 19,300 | 10,799 | 4,605 |
| Common Stock Repurchased | -100 | -100 | -33,100 | -83 | -83 |
| Other Financing Activity | -7,300 | -6,700 | -37,600 | -29,397 | -26,464 |
| Financing Cash Flow | $1,100 | $-2,100 | $-51,400 | $-18,681 | $-21,942 |
| Exchange Rate Effect | -100 | N/A | N/A | -74 | -12 |
| Beginning Cash Position | 179,300 | 179,300 | 272,500 | 271,513 | 271,513 |
| End Cash Position | 191,300 | 164,600 | 179,300 | 340,991 | 315,627 |
| Net Cash Flow | $12,000 | $-14,700 | $-93,200 | $69,478 | $44,114 |
| Free Cash Flow | |||||
| Operating Cash Flow | 33,600 | -1,000 | 208,100 | 130,614 | 95,673 |
| Capital Expenditure | -25,200 | -11,600 | -54,800 | -42,381 | -29,605 |
| Free Cash Flow | 8,400 | -12,600 | 153,300 | 88,233 | 66,068 |